Ying Shi

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Clinical Evaluation

Top Venues

Cancer biology & medicine

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Luoyi Chen, Xinchen Zhao, Xiaowei Liu, Yujie Ouyang, Chuan Xu, Ying Shi
Development of small molecule drugs targeting immune checkpoints. Cancer biology & medicine (2024)
Luoyi Chen, Xinchen Zhao, Xiaowei Liu, Yujie Ouyang, Chuan Xu, Ying Shi
Development of small molecule drugs targeting immune checkpoints. Cancer biology & medicine 21 (5) (2024)
Luoyi Chen, Xinchen Zhao, Xiaowei Liu, Yujie Ouyang, Chuan Xu, Ying Shi
Development of small molecule drugs targeting immune checkpoints. Cancer biology & medicine 21 (5) (2024)
Luoyi Chen, Xinchen Zhao, Xiaowei Liu, Yujie Ouyang, Chuan Xu, Ying Shi
Development of small molecule drugs targeting immune checkpoints. Cancer biology & medicine 21 (5) (2024)
Ying Shi, Jin Shang, Yan Li, Deyuan Zhong, Zilong Zhang, Qinyan Yang, Chunyou Lai, Tianhang Feng, Yutong Yao, Xiaolun Huang
ITGA5 and ITGB1 contribute to Sorafenib resistance by promoting vasculogenic mimicry formation in hepatocellular carcinoma. Cancer medicine (2022)